Treatment for Multiple Sclerosis

Treatment for multiple sclerosis is designed to help a person be as independent as possible while also dealing with the emotions (such as anxiety, anger, depression, or fear) that can accompany this disease. Medications, physical and occupational therapy, and emotional support may all be part of a person's treatment for multiple sclerosis.

 

Treatment for Multiple Sclerosis: An Introduction

At this time, there is no cure for MS. However, researchers continue to make great advancements in the understanding and treatment of this disease.
 
Current treatment for multiple sclerosis focuses on controlling the immune system and managing the symptoms of multiple sclerosis. It is important for people to work with their healthcare providers to find the best approach to address multiple sclerosis symptoms such as extreme fatigue, bladder problems, and spasticity (muscle tightness and stiffness).
 
Specific MS treatments can include:
 
  • Medications
  • Physical or occupational therapy
  • Emotional support.
     

Medications Used in the Treatment for Multiple Sclerosis

There are three basic goals when using medications as a treatment for multiple sclerosis:
 
 
  • Manage the exacerbations or relapses of MS, which are the attacks where new symptoms appear or the old symptoms get worse
  • Modify the disease itself
  • Manage MS-related symptoms. 

 

Treatment for Multiple Sclerosis That Modifies the Disease
Three forms of beta interferon (Avonex®, Betaseron®, and Rebif®) have now been approved by the Food and Drug Administration (FDA) for treatment of relapsing-remitting MS. Beta interferon has been shown to reduce the number of exacerbations and may slow down the progression of physical disability. When attacks do occur, they tend to be shorter and less severe.
 
The FDA also has approved a synthetic form of myelin basic protein, called copolymer I (Copaxone®), for the treatment of relapsing-remitting MS. Copolymer I has few side effects, and studies indicate that the agent can reduce the relapse rate by almost one-third.
 
An immunosuppressant treatment for multiple sclerosis, Novantrone® (mitoxantrone), is approved by the FDA for the treatment of advanced or chronic MS.
(Treatment for Multiple Sclerosis Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: Arthur Schoenstadt, MD